CO6351790A2 - Derivados de carbonato de quinuclidina y composicion medicinal de los mismos - Google Patents
Derivados de carbonato de quinuclidina y composicion medicinal de los mismosInfo
- Publication number
- CO6351790A2 CO6351790A2 CO11013721A CO11013721A CO6351790A2 CO 6351790 A2 CO6351790 A2 CO 6351790A2 CO 11013721 A CO11013721 A CO 11013721A CO 11013721 A CO11013721 A CO 11013721A CO 6351790 A2 CO6351790 A2 CO 6351790A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- optionally substituted
- nr2co
- formula
- group selected
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invención está dirigida a derivados de carbonato de quinuclidina de fórmula general (I)donde: A puede ser arilo o heteroarilo o arilalquilo o heteroarilalquilo o un grupo de fórmula (a) opcionalmente sustituidoDonde R3 y R4 son iguales o diferentes con la condición de que R3 y R4 nunca son ambos H.R es un residuo seleccionado entre:- (C1-C10)-alquilo, (C2-C10)-alquenilo y (C2-C10)-alquinilo opcionalmente sustituido con un grupo seleccionado entre:- un grupo seleccionado entre de NH2, NR1R2, CONR1R2, NR2COR1, OH, SOR1, SO2R1, SH, CN, NO2 ycompuestos alicíclicos;- Z-R1, donde Z se selecciona entre CO, O, COO, OCO, SO2, S, SO, COS y SCO o es una unión y- (C3-C8)-cicloalquilo.R1 es un residuo seleccionado entre:- compuesto alicíclico opcionalmente sustituido con uno o varios sustituyentes seleccionados independientemente entre OH, oxo (=O), SH, NO2, CN, CONH2, NR2CO-(C1-Cx)-aIquilo, COOH, (C1-C10)- alcoxicarbonilo, (C1-C10)-alquilsulfanilo, (C1-C10)-alquilsulfinilo, (C1-C10)alquilsulfonilo, (C1-C10)-alquilo y (C1-C10)-alcoxilo NR2CO-(C1-C10)- alquilo;- arilo opcionalmente sustituido con NR2CO-(C1-C10)-alquilo, (C1-C10)-alquilo, O-(C1-C10)-alquilo o halógeno y- heteroarilo opcionalmente sustituido con NR2CO-(C1-C10)-alquilo o halógeno.R2 es un grupo seleccionado entre H, fenoxicarbonilo, benciloxicarbonilo, (C1-C10)-alcoxicarbonilo, (C1-C10)-alquilcarbonilo, (C1-C10)-alquilsulfonilo y (C1-C10)-alquilo.X´ es un anión aceptable fisiológicamente.La presente invención también provee composiciones farmacéuticas de compuestos de fórmula (I) solos o en combinación con o en mezcla con uno o más vehículos y/o excipientes farmacéuticamente aceptables.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08162066A EP2154136A1 (en) | 2008-08-08 | 2008-08-08 | Quinuclidine carbonate derivatives and medicinal compositions thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6351790A2 true CO6351790A2 (es) | 2011-12-20 |
Family
ID=40228074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO11013721A CO6351790A2 (es) | 2008-08-08 | 2011-02-07 | Derivados de carbonato de quinuclidina y composicion medicinal de los mismos |
Country Status (32)
Country | Link |
---|---|
US (3) | US8039483B2 (es) |
EP (2) | EP2154136A1 (es) |
JP (1) | JP2011530489A (es) |
KR (1) | KR20110044221A (es) |
CN (1) | CN102112474B (es) |
AR (1) | AR072994A1 (es) |
AT (1) | ATE551341T1 (es) |
AU (1) | AU2009278306B2 (es) |
CA (1) | CA2733380A1 (es) |
CO (1) | CO6351790A2 (es) |
CY (1) | CY1112724T1 (es) |
DK (1) | DK2313404T3 (es) |
EA (1) | EA019166B1 (es) |
ES (1) | ES2384914T3 (es) |
GE (1) | GEP20135744B (es) |
HK (1) | HK1156032A1 (es) |
HR (1) | HRP20120394T1 (es) |
IL (1) | IL211103A (es) |
JO (1) | JO2831B1 (es) |
MA (1) | MA32622B1 (es) |
ME (1) | ME01283A (es) |
MX (1) | MX2011001504A (es) |
MY (1) | MY156332A (es) |
NZ (1) | NZ590987A (es) |
PL (1) | PL2313404T3 (es) |
PT (1) | PT2313404E (es) |
RS (1) | RS52370B (es) |
SI (1) | SI2313404T1 (es) |
TW (1) | TWI455938B (es) |
UA (1) | UA102857C2 (es) |
WO (1) | WO2010015324A1 (es) |
ZA (1) | ZA201100963B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009079078A1 (en) | 2007-12-14 | 2009-06-25 | Labogroup S.A.S. | Delivering aerosolizable food products |
EP2154136A1 (en) | 2008-08-08 | 2010-02-17 | CHIESI FARMACEUTICI S.p.A. | Quinuclidine carbonate derivatives and medicinal compositions thereof |
EP2206712A1 (en) | 2008-12-23 | 2010-07-14 | CHIESI FARMACEUTICI S.p.A. | "Alkaloid aminoester derivatives and medicinal composition thereof" |
HUE038555T2 (hu) | 2010-04-21 | 2018-10-29 | Chiesi Farm Spa | Eljárás csökkentett elektrosztatikus töltéssel rendelkezõ részecskék elõállítására |
EP2585458B1 (en) | 2010-06-22 | 2015-01-07 | Chiesi Farmaceutici S.p.A. | Alkaloid aminoester derivatives and medicinal compositions thereof |
CA2803416A1 (en) | 2010-06-22 | 2011-12-29 | Chiesi Farmaceutici S.P.A. | Alkaloid aminoester derivatives and medicinal composition thereof |
CA2803459A1 (en) | 2010-06-22 | 2011-12-29 | Chiesi Farmaceutici S.P.A. | Alkaloid aminoester derivatives and medicinal compositions thereof |
BR112013007022B1 (pt) | 2010-09-30 | 2019-10-15 | Chiesi Farmaceutici S.P.A | Uso de estearato de magnésio |
EP2630145A1 (en) * | 2010-10-20 | 2013-08-28 | Chiesi Farmaceutici S.p.A. | Carbonate derivatives for the treatment of cough |
CN103221390B (zh) | 2010-11-26 | 2015-06-03 | 奇斯药制品公司 | 甘氨酸衍生物及其医药组合物 |
PT2685986T (pt) * | 2011-03-18 | 2020-03-05 | Genzyme Corp | Inibidor de glicosilceramida-sintase |
EP2702041A1 (en) * | 2011-04-29 | 2014-03-05 | Chiesi Farmaceutici S.p.A. | Alkaloid ester and carbamate derivatives and medicinal compositions thereof |
WO2013098145A1 (en) | 2011-12-30 | 2013-07-04 | Chiesi Farmaceutici S.P.A. | Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof |
MA37975B2 (fr) * | 2012-09-11 | 2021-03-31 | Genzyme Corp | Inhibiteurs de synthase de glucosylcéramide |
US9427376B2 (en) | 2013-10-10 | 2016-08-30 | Chiesi Farmaceutici S.P.A. | Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient |
CA3166777A1 (en) | 2020-02-03 | 2021-08-12 | Nigel Patrick Somerville CRAWFORD | Methods for treating neurological symptoms associated with lysosomal storage diseases |
TW202220648A (zh) | 2020-07-24 | 2022-06-01 | 美商健臻公司 | 包含芬谷司他(venglustat)之醫藥組合物 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2165768B1 (es) * | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
BR0116450A (pt) | 2000-12-22 | 2003-09-30 | Almirall Prodesfarma Ag | Composto, processos para a preparação de um carbamato, e para produzir um sal, composição farmacêutica, uso de um composto ou de uma composição farmacêutica, e, produto de combinação |
EP1383730A2 (en) * | 2001-04-03 | 2004-01-28 | Aryx Therapeutics | Anticholinergic compounds and methods of use |
US7452904B2 (en) | 2001-12-20 | 2008-11-18 | Chiesi Farmaceutici S.P.A. | 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives and their use as muscarinic receptor antagonists |
EP1882691A1 (en) * | 2006-07-26 | 2008-01-30 | CHIESI FARMACEUTICI S.p.A. | Quinuclidine derivatives as M3 antagonists |
EP2154136A1 (en) | 2008-08-08 | 2010-02-17 | CHIESI FARMACEUTICI S.p.A. | Quinuclidine carbonate derivatives and medicinal compositions thereof |
EP2206712A1 (en) | 2008-12-23 | 2010-07-14 | CHIESI FARMACEUTICI S.p.A. | "Alkaloid aminoester derivatives and medicinal composition thereof" |
BR112012032330A2 (pt) | 2010-06-22 | 2016-11-08 | Chiesi Farma Spa | formulação em pó seco inalável, uso de uma formulação em pó seco, inalador de pó seco e embalagem |
EP2630145A1 (en) | 2010-10-20 | 2013-08-28 | Chiesi Farmaceutici S.p.A. | Carbonate derivatives for the treatment of cough |
US20120220557A1 (en) | 2011-02-17 | 2012-08-30 | Chiesi Farmaceutici S.P.A. | Liquid propellant-free formulation comprising an antimuscarinic drug |
EP2702041A1 (en) | 2011-04-29 | 2014-03-05 | Chiesi Farmaceutici S.p.A. | Alkaloid ester and carbamate derivatives and medicinal compositions thereof |
-
2008
- 2008-08-08 EP EP08162066A patent/EP2154136A1/en not_active Withdrawn
-
2009
- 2009-07-21 EA EA201100161A patent/EA019166B1/ru not_active IP Right Cessation
- 2009-07-21 WO PCT/EP2009/005272 patent/WO2010015324A1/en active Application Filing
- 2009-07-21 PL PL09777321T patent/PL2313404T3/pl unknown
- 2009-07-21 MY MYPI2011000542A patent/MY156332A/en unknown
- 2009-07-21 UA UAA201101383A patent/UA102857C2/ru unknown
- 2009-07-21 EP EP09777321A patent/EP2313404B1/en active Active
- 2009-07-21 ES ES09777321T patent/ES2384914T3/es active Active
- 2009-07-21 RS RS20120262A patent/RS52370B/en unknown
- 2009-07-21 CN CN200980130187.4A patent/CN102112474B/zh active Active
- 2009-07-21 ME MEP-2011-24A patent/ME01283A/me unknown
- 2009-07-21 DK DK09777321.2T patent/DK2313404T3/da active
- 2009-07-21 MX MX2011001504A patent/MX2011001504A/es active IP Right Grant
- 2009-07-21 JP JP2011521454A patent/JP2011530489A/ja active Pending
- 2009-07-21 AT AT09777321T patent/ATE551341T1/de active
- 2009-07-21 NZ NZ590987A patent/NZ590987A/xx not_active IP Right Cessation
- 2009-07-21 AU AU2009278306A patent/AU2009278306B2/en not_active Ceased
- 2009-07-21 GE GEAP200912093A patent/GEP20135744B/en unknown
- 2009-07-21 CA CA2733380A patent/CA2733380A1/en not_active Abandoned
- 2009-07-21 SI SI200930266T patent/SI2313404T1/sl unknown
- 2009-07-21 KR KR1020117002974A patent/KR20110044221A/ko not_active Application Discontinuation
- 2009-07-21 PT PT09777321T patent/PT2313404E/pt unknown
- 2009-07-30 US US12/512,262 patent/US8039483B2/en active Active
- 2009-08-06 JO JO2009296A patent/JO2831B1/en active
- 2009-08-06 TW TW098126682A patent/TWI455938B/zh not_active IP Right Cessation
- 2009-08-07 AR ARP090103053A patent/AR072994A1/es unknown
-
2011
- 2011-02-07 CO CO11013721A patent/CO6351790A2/es active IP Right Grant
- 2011-02-07 ZA ZA2011/00963A patent/ZA201100963B/en unknown
- 2011-02-07 IL IL211103A patent/IL211103A/en not_active IP Right Cessation
- 2011-03-08 MA MA33683A patent/MA32622B1/fr unknown
- 2011-08-26 US US13/219,109 patent/US8440690B2/en active Active
- 2011-09-14 US US13/232,415 patent/US8404712B2/en active Active
- 2011-10-03 HK HK11110402.8A patent/HK1156032A1/xx unknown
-
2012
- 2012-05-10 HR HRP20120394AT patent/HRP20120394T1/hr unknown
- 2012-05-11 CY CY20121100443T patent/CY1112724T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6351790A2 (es) | Derivados de carbonato de quinuclidina y composicion medicinal de los mismos | |
MX2009004910A (es) | Compuestos sustituidos de 3-isobutil-9,10-dimetoxi-1,3,4,6,7,11-b- hexahidro-2h-pirido[2,1-a] isoquinolin-2-ol y métodos que se relacionan al mismo. | |
MX2007004699A (es) | Derivados de indol y bencimidazol. | |
HUP0400699A2 (hu) | Fenetanolaminszármazékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények | |
WO2008065500A3 (en) | Heteroaryl amides as type i glycine transport inhibitors | |
UA94052C2 (uk) | Похідні піридазину | |
IL160769A (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
RU2012100913A (ru) | ПРОТИВООПУХОЛЕВЫЕ КОМБИНАЦИИ С ИНГИБИТОРАМИ mTOR, ГЕРЦЕПТИНОМ И/ИЛИ HKI-272 | |
DOP2002000392A (es) | Sales tartrato de 5,8,14 triazatetraciclo [10.3.1.024 0.4.9] hexadeca-2 (11), 3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas | |
MY148988A (en) | Terphenyl derivatives for treatment of alzheimer's disease | |
CA2545427A1 (en) | Selective kinase inhibitors | |
WO2006039668B1 (en) | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection | |
MY139571A (en) | Indolyl derivatives as liver-x-receptor modulators | |
MX2010008101A (es) | Derivados de indol 2-carboxamidas y de azaindol 2-carboxamidas sustituidos con un silanilo, su preparacion y su aplicacion en terapeutica. | |
TW200744659A (en) | Preparation for preventing and ameliorating wrinkle | |
EA201201052A1 (ru) | Замещенные нафтиридины и их применение в качестве ингибиторов киназы syk | |
EA201201414A1 (ru) | КОМБИНАЦИИ, СОДЕРЖАЩИЕ ЗАМЕЩЕННЫЕ 2,3-ДИГИДРОИМИДАЗО[1,2-c]ХИНАЗОЛИНЫ | |
TW200630364A (en) | 2-amido-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
EA200601178A1 (ru) | Морфолинилсодержащие бензимидазолы в качестве ингибиторов репликации респираторно-синцитиального вируса | |
MX2009003169A (es) | Derivados de sulfonamida. | |
UY27980A1 (es) | Indoles 2,7-sustituidos | |
TW200745096A (en) | Indole derivatives | |
AR033399A1 (es) | Malonamida y derivados del ester malonamico con actividad antitrombotica, un proceso para su preparacion y composicion farmaceutica | |
MX2024003130A (es) | Amida 1,4-dihidro-1,6-naftiridina sustituida y uso de la misma. | |
ATE435204T1 (de) | 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1 3-dihydro-2h-indol-2-on-derivate und verwandte verbindungen zur behandlung von erkrankungen des zentralnervensystems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Application granted |